Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine patches for prevention of COVID-19 infection in hospital staff
2020-003722-23Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2020
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-arm trial of V0116 and nicotine in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Time to documented symptomatic COVID-19 infection. Started Aug 2020; status: completed.
02
Drugs
V0116nicotine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003722-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003722-23.